Connecticut Oncology Group — Middletown, Connecticut

Connecticut Oncology Group is a clinical research site located in Middletown, Connecticut, United States 06457.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Connecticut Oncology Group has participated in 4 clinical trials.

Therapeutic areas: Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms.

Sponsors: Novartis, Genentech, Inc., Dartmouth-Hitchcock Medical Center.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Connecticut Oncology Group?

Connecticut Oncology Group has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Connecticut Oncology Group conducted?

Connecticut Oncology Group has 4 clinical trials on record. Their work covers Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms.

Is Connecticut Oncology Group accredited by Crixeo Health?

Yes — Connecticut Oncology Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Connecticut Oncology Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.